Deutsche Bank’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $94.7K | Sell |
28,094
-35
| -0.1% | -$118 | ﹤0.01% | 3268 |
|
2025
Q1 | $109K | Buy |
28,129
+35
| +0.1% | +$135 | ﹤0.01% | 3139 |
|
2024
Q4 | $173K | Hold |
28,094
| – | – | ﹤0.01% | 3094 |
|
2024
Q3 | $151K | Hold |
28,094
| – | – | ﹤0.01% | 3010 |
|
2024
Q2 | $94.1K | Hold |
28,094
| – | – | ﹤0.01% | 3099 |
|
2024
Q1 | $113K | Hold |
28,094
| – | – | ﹤0.01% | 3072 |
|
2023
Q4 | $74.4K | Buy |
28,094
+27,585
| +5,419% | +$73.1K | ﹤0.01% | 3296 |
|
2023
Q3 | $1.2K | Sell |
509
-15,392
| -97% | -$36.3K | ﹤0.01% | 3585 |
|
2023
Q2 | $100K | Sell |
15,901
-8,955
| -36% | -$56.4K | ﹤0.01% | 3267 |
|
2023
Q1 | $143K | Buy |
24,856
+7,015
| +39% | +$40.5K | ﹤0.01% | 3167 |
|
2022
Q4 | $183K | Buy |
17,841
+4,082
| +30% | +$41.9K | ﹤0.01% | 3015 |
|
2022
Q3 | $230K | Sell |
13,759
-2,261
| -14% | -$37.8K | ﹤0.01% | 2851 |
|
2022
Q2 | $224K | Buy |
16,020
+1,230
| +8% | +$17.2K | ﹤0.01% | 3080 |
|
2022
Q1 | $239K | Sell |
14,790
-2,228
| -13% | -$36K | ﹤0.01% | 3143 |
|
2021
Q4 | $364K | Buy |
17,018
+9,003
| +112% | +$193K | ﹤0.01% | 3011 |
|
2021
Q3 | $118K | Buy |
8,015
+15
| +0.2% | +$221 | ﹤0.01% | 3774 |
|
2021
Q2 | $159K | Buy |
+8,000
| New | +$159K | ﹤0.01% | 3862 |
|